Q07011 (TNR9_HUMAN) Homo sapiens (Human)
Tumor necrosis factor receptor superfamily member 9 UniProtKBInterProSTRINGInteractive Modelling
255 aa; Sequence (Fasta)
Available Structures
13 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Structure of human 4-1BB / 4-1BBL complex |
Heteromer P41273; | 3×NAG; 5×ACT; 4×GOL; | ||||
| Assess | ||||||
| Structure of the human 4-1BB / Urelumab Fab complex |
Heteromer | 1×NAG; 1×GOL; 1×EPE; | ||||
| Assess | ||||||
| Crystal structure of 4-1BB in complex with a VHH |
Heteromer | 1×NAG; 1×NAG; 3×CL; 3×SO4; 2×EDO; | ||||
| Assess | ||||||
| Complex structure of human 4-1BB and 4-1BBL |
Heteromer P41273; | 1×NAG; | ||||
| Assess | ||||||
| Crystal Structure of the 4-1BB in complex with ZG033 Fab |
Heteromer | 1×NAG; 1×GOL; | ||||
| Assess | ||||||
| Structure of the human 4-1BB / Utomilumab Fab complex |
Heteromer | 14×SO4; 7×GOL; 1×NAG; | ||||
| Assess | ||||||
| Complex structure of 4-1BB and utomilumab |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of agonistic antibody 1618 fab domain bound to human 4-1BB. |
Heteromer | 1×TMO; 1×MN; | ||||
| Assess | ||||||
| Crystal Structure of the 4-1BB/4-1BBL Complex |
Heteromer P41273; | 3×PEG; | ||||
| Assess | ||||||
| Crystal structure of 4-1BBL/4-1BB complex in C2 space group |
Heteromer P41273; | 1×GOL; 7×CL; 6×SO4; 3×NAG; 2×NA; | ||||
| Assess | ||||||
| Crystal structure of scFv ATOR 1017 bound to human 4-1BB |
Heteromer | |||||
| Assess | ||||||
| Crystal structure of 4-1BBL/4-1BB (C121S) complex in P21 space group |
Heteromer P41273; | 1×NAG; | ||||
| Assess | ||||||
| Crystal structure of CD137 in complex with the cyclic peptide BCY10916 | monomer | 1×ACT; 1×EDO; 3×SO4; 1×NA; 1×29N; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8gye.2.C | monomer | 0.73 | 100.00 | |||
| Assess | ||||||